DBV Technologies SA (NASDAQ:DBVT)

9.85
Delayed Data
As of 10:48am ET
 -0.03 / -0.30%
Today’s Change
3.60
Today|||52-Week Range
25.77
+53.43%
Year-to-Date
Here's Why Aimmune Therapeutics Fell 7% Today
Jul 11 / MotleyFool.com - Paid Partner Content
DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Off...
Jun 26 / GlobeNewswirePNW - Paid Partner Content